- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06160986
Horizons Chronic Graft-Versus-Host-Disease Study
February 1, 2024 updated by: Lara Traeger, University of Miami
Multidisciplinary Intervention for Adults With Chronic Graft Versus Host Disease
This research is being done to evaluate the feasibility of the Horizons Program, a group-based behavioral intervention, to enhance quality of life in patients with chronic graft-versus-host disease.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lara Traeger, PhD
- Phone Number: 3052843012
- Email: ltraeger@miami.edu
Study Contact Backup
- Name: Milan Pasic, BA
- Phone Number: 3052843012
- Email: mpasic95@miami.edu
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- Recruiting
- University of Miami
-
Principal Investigator:
- Lara Traeger, PhD
-
Contact:
- Lara Traeger, PhD
- Phone Number: 305-284-3012
- Email: ltraeger@miami.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- underwent allogeneic hematopoietic stem cell transplant
- have moderate to severe chronic graft versus host disease
- currently receiving care at the Sylvester Comprehensive Cancer Center Bone Marrow Transplant Program
- able to participate in a group intervention in English or Spanish language
Exclusion Criteria:
- comorbid conditions or cognitive impairment that the treating clinician believes prohibits informed consent or participation in the intervention
- vulnerable patients, defined here as prisoners and pregnant women
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Horizons Group
Participants will receive the Horizons Group intervention for up to 8 weeks.
|
The Horizons Group intervention in English or Spanish language (per participant preference) contains 8 weekly group sessions delivered via video conference by a bone marrow transplant clinician and behavioral health specialist, over approximately 8 weeks, approximately 1.5 hours per session every week.
The intervention pairs state-of-the-science information about survivorship and chronic graft versus host disease with self-management strategies.
Intervention sessions will be delivered via video conference (Zoom), which participants may access by computer, laptop, tablet, or smart phone.
As part of the intervention, participants will have access to an intervention manual and audio-recorded relaxation exercises to support learning and skills practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of participant enrollment
Time Frame: Baseline (pre-intervention) to 10-week follow-up
|
Participant enrollment will be demonstrated if ≥50% eligible participants enroll
|
Baseline (pre-intervention) to 10-week follow-up
|
Percentage of participant attendance
Time Frame: Baseline (pre-intervention) to 10-week follow-up
|
Participant attendance will be demonstrated if ≥80% participants complete ≥4 of 8 sessions
|
Baseline (pre-intervention) to 10-week follow-up
|
Percentage of participant retention
Time Frame: Baseline (pre-intervention) to 10-week follow-up
|
Participant retention will be demonstrated if ≥80% participants are retained in the study at week 10.
|
Baseline (pre-intervention) to 10-week follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lara Traeger, PhD, University of Miami
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 27, 2023
Primary Completion (Estimated)
July 1, 2024
Study Completion (Estimated)
April 1, 2025
Study Registration Dates
First Submitted
November 29, 2023
First Submitted That Met QC Criteria
November 29, 2023
First Posted (Actual)
December 7, 2023
Study Record Updates
Last Update Posted (Estimated)
February 5, 2024
Last Update Submitted That Met QC Criteria
February 1, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20230656
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Horizons Group Intervention
-
Emory UniversityNational Institutes of Health (NIH)Completed
-
East Carolina UniversityOhio UniversityRecruiting
-
Ohio UniversityLehigh UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Emory UniversityCompletedSexually Transmitted DiseasesUnited States
-
Johns Hopkins Bloomberg School of Public HealthNative American Research Centers for Health; White Mountain Apache TribeNot yet recruiting
-
University of SheffieldCompletedQuality of Life | Psychological Distress | Body Image | Dermatologic DiseaseUnited Kingdom
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...RecruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Hospital de Clinicas de Porto AlegreUnknown